- Report
- June 2025
- 150 Pages
Global
From €2457EUR$2,699USD£2,114GBP
- Report
- June 2025
- 81 Pages
Global
From €3500EUR$4,119USD£3,118GBP
- Report
- February 2024
- 126 Pages
Global
From €2313EUR$2,542USD£1,991GBP
€2722EUR$2,990USD£2,342GBP
The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements.
Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels.
The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more